Axa’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,700
| Closed | -$154K | – | 1184 |
|
|
2022
Q4 | $154K | Sell |
13,700
-139,725
| -91% | -$1.57M | ﹤0.01% | 1102 |
|
|
2022
Q3 | $1.56M | Hold |
153,425
| – | – | 0.01% | 793 |
|
|
2022
Q2 | $1.39M | Sell |
153,425
-33,075
| -18% | -$300K | 0.01% | 827 |
|
|
2022
Q1 | $1.78M | Sell |
186,500
-4,300
| -2% | -$41.1K | 0.01% | 852 |
|
|
2021
Q4 | $2.11M | Sell |
190,800
-28,000
| -13% | -$309K | 0.01% | 835 |
|
|
2021
Q3 | $1.62M | Buy |
+218,800
| New | +$1.62M | ﹤0.01% | 897 |
|
|
2016
Q4 | – | Sell |
-13,841
| Closed | -$502K | – | 1291 |
|
|
2016
Q3 | $502K | Buy |
+13,841
| New | +$502K | ﹤0.01% | 1022 |
|
|
2015
Q4 | – | Sell |
-3,200
| Closed | -$35K | – | 1487 |
|
|
2015
Q3 | $35K | Hold |
3,200
| – | – | ﹤0.01% | 1378 |
|
|
2015
Q2 | $42K | Buy |
+3,200
| New | +$42K | ﹤0.01% | 1338 |
|